Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 1,259,688 | $125,968,784.00 | 5.1% |
Safran SA | Equity | 237,113 | $77,060,872.00 | 3.12% |
SAP SE | Equity | 230,113 | $69,974,554.00 | 2.83% |
Rolls-Royce Holdings PLC | Equity | 4,892,689 | $64,983,528.00 | 2.63% |
ASML Holding NV | Equity | 72,218 | $57,642,885.00 | 2.33% |
Novo Nordisk AS, Class B | Equity | 711,428 | $49,377,343.00 | 2% |
AstraZeneca PLC | Equity | 350,943 | $48,750,257.00 | 1.97% |
London Stock Exchange Group PLC | Equity | 324,188 | $47,325,395.00 | 1.92% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 203,993 | $46,202,375.00 | 1.87% |
Airbus SE, non-registered shares | Equity | 210,096 | $43,868,763.00 | 1.78% |
UniCredit SpA | Equity | 620,545 | $41,599,559.00 | 1.68% |
ABB, Ltd. | Equity | 686,232 | $40,917,053.00 | 1.66% |
Hong Kong Exchanges and Clearing, Ltd. | Equity | 760,400 | $40,567,841.00 | 1.64% |
Amadeus IT Group SA, Class A, non-registered shares | Equity | 478,177 | $40,262,439.00 | 1.63% |
DSV A/S | Equity | 155,694 | $37,413,265.00 | 1.51% |